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Abstract  
Objective: To examine the association between parent reports of intimate partner violence (IPV) 
and depressive symptoms within the first 3 years of a child’s life with subsequent mental health 
conditions and psychotropic drug treatment. 
Design: Prospective cohort study linking parental IPV and depression with subsequent billing 
and pharmacy data. 
Setting: 4 pediatric clinics between November 2004 and June 2012 
Patients/Participants: 2,422 children  
Main Exposure: Any report of IPV and/or parental depressive symptoms from birth to 3 years 
of age. 
Main Outcome Measures: ICD-9 mental health diagnoses and any psychotropic drug treatment 
between 3 and 6 years of age. 
Results: 2.4% of caregivers (n=58) reported both IPV and depressive symptoms before their 
children were 3 years of age, 3% (n=69) of caregivers reported IPV only, 29% (n=704) reported 
depressive symptoms only, and 65.7% (n=1,591) reported neither exposure.  Children of parents 
reporting both IPV and depressive symptoms were more likely to have a diagnosis of attention-
deficit hyperactivity disorder (ADHD) (AOR 4.0; 95% CI: 1.5-10.9), even after adjusting for 
child gender, race/ethnicity, and insurance type.  Children whose parents reported depressive 
symptoms were more likely to have been prescribed psychotropic medication (AOR 1.9; 95% 
CI: 1.0-3.4).    
Conclusions: Exposure to both IPV and depression before 3 years is associated with preschool-
onset ADHD; and early exposure to parental depression is associated with being prescribed 




Approximately 1 in 4 women and 1 in 7 men report experiencing some form of intimate 
partner violence (IPV) over their lifetimes, with an estimated 1.5 million women being 
physically abused or raped by an intimate partner in the United States each year.1-5  The Centers 
for Disease Control and Prevention defines IPV as “a pattern of coercive behaviors that may 
include repeated battering and injury, psychological abuse, sexual assault, progressive social 
isolation, deprivation and intimidation.”2  Such violence increases the likelihood of long-term 
physical and mental health effects for victims, including depression, post-traumatic stress and 
substance abuse, physical ailments such as chronic pain and headaches, and lower self-esteem.6-9   
It has been estimated that every year at least 1.5 million children witness IPV,2-5 which 
has been associated with increased risk for behavioral and mental health problems.10-13  One 
explanation for this may be that mothers experience impaired functioning following episodes of 
violence, which then impacts childhood behavioral outcomes.13,14 Exposure to IPV and parental 
depression together have also been linked to behavioral problems and poor school functioning.15 
Moreover, witnessing IPV as a child is a known risk factor for experiencing IPV and poor health 
in adulthood.16 Independent of IPV-related depression, it has also been shown that exposure to 
any parental depression puts children at greater risk for decreased cognitive ability and increased 
behavioral problems.15,17-20 These negative outcomes are true regardless of the timing of 
exposure to parental depression.21-25  
These studies provide support for the idea that pediatricians should actively screen for 
IPV and parental depression along with other risk factors associated with poor childhood 
behavioral health outcomes.  However, most studies examining the effects of IPV on children are 
drawn from high-risk samples, such as families seeking assistance from battered women shelters 
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or court-reported IPV.11,26-30 Moreover, a majority of studies examining the association between 
IPV and childhood behavioral health outcomes have been among school-aged children.12,15,31,32  
Far less is known about this association among preschoolers.33  This study not only adds to 
existing literature showing that IPV and parental depression are associated with childhood 
mental health, behavioral and social concerns; but also expands upon it by focusing on the 
manifestations of these problems in a younger and more generalizable population of preschool-
aged children seen in primary care settings. This study is also distinguished by its prospective 
study design.      
 
Methods 
Patients and Methods 
Study Design 
This prospective cohort study followed children in four Indianapolis community health 
centers where families were routinely screened for IPV and depression during the course of 
routine primary care clinical encounters.  Billing and pharmacy claims data were extracted from 
the Regenstrief Medical Record System (RMRS) and Indiana Network for Patient Care (INPC) 




The Child Health Improvement through Computer Automation (CHICA) system is a 
comprehensive pediatric primary care computerized clinical decision support system comprising 
a knowledge base of guideline rules, a repository of patient data, a tailored printing and scanning 
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engine, and business rules that direct the communication, printing, and scanning of patient-
specific documents.34  CHICA, currently utilized in four primary care practices, has provided 
real-time decision support for more than 32,000 pediatric patients since its launch in 2004.  
Data for this study were captured from the pre-screener form (PSF) that parents complete 
in the waiting room.  The functionality of CHICA has been described elsewhere,34-37 but in brief, 
the PSF includes 20 health assessment questions, drawn from a roster of national guidelines for 
preventive and chronic care that are specifically selected for inclusion based on the child’s age 
and history.37  The PSF is then scanned back into the CHICA system by the nursing staff prior to 
the physician encounter.  
Previous studies have demonstrated the feasibility of screening for IPV in pediatric 
settings, and universal screening in these settings has been shown to increase significantly the 
number of victims identified.38,39  For these reasons, screening questions specific to IPV were 
added to CHICA’s library of queries in 2004.   
Outcome data for this study were obtained from the Regenstrief Medical Record System 
(RMRS).  The RMRS has supported the county hospital system since the mid-1970s, and was 
expanded in 2004 to form the Indiana Network for Patient Care (INPC).40  A statewide health 
information exchange built for the interchange of standardized and interoperable clinical data for 
clinical, public health, and research purposes, the INPC currently includes clinical data from 45 
hospitals and the laboratories, imaging centers, pharmacies, and large-group practices tied 




For the purposes of this study, we focused on children receiving care at clinics served by 
the CHICA system from November 2004 to June 2012.  In order to quantify parent reports of 
IPV, parental depressive symptoms and subsequent mental health diagnoses and/or psychotropic 
treatment, we included subjects who had at least 2 visits documented in CHICA: one visit falling 
between birth and 36 months (3 years) to classify exposures to IPV and parental depressive 
symptoms, and a second visit falling between 37 months and 72 months (6 years) to classify the 
outcomes of interest.  
 
Measures 
Intimate Partner Violence (IPV) 
The IPV screening questions on the PSF are: (1) “Has your partner kicked, hit or slapped 
you?” and (2) “Do you feel safe in your home?”  Both questions are asked annually for children 
younger than 11 years.  We defined a child as having IPV exposure if there was a positive 
response to either question at any visit between birth and 36 months of age.  If no affirmative 
responses were captured for any visits during this timeframe, the child was categorized as having 
no IPV exposure.  If all visits captured in this timeframe had no data captured, we considered the 
data missing.  
 
Parental Depressive Symptoms 
Initially, the depression-screening items printed on the PSF were derived from the Patient 
Health Questionnaire-2 (PHQ-2),41 which measures parental report of depressed mood (“Parents 
often get depressed.  In the past month, how often have you felt down, depressed or hopeless?”) 
and anhedonia (“In the past month, have you lost interest or pleasure in doing things?”).  In 
	 9
2010, these questions were replaced by adaptations of the 3 anxiety subscale items from the 
Edinburgh Postnatal Depression Scale (EPDS-3)42: “In the past 7 days, have you blamed yourself 
unnecessarily when things went wrong?”; “In the past 7 days, have you felt scared or panicky for 
not a very good reason?”; and “In the past 7 days, have you been anxious or worried for no good 
reason?”  This screening tool has been shown to have high sensitivity (95%) and a negative 
predictive value (98%) for postpartum depression.  CHICA prints these parental mood questions 
on the PSF every 90 days during the first 15 months of life.  If a parent endorsed any of the 
surveillance items at any visit within the first 3 years of life, a child was considered to be 
exposed to parental depressive symptoms.    
 
Socio-demographic Characteristics 
Child gender, race/ethnicity, and insurance type were all obtained from the CHICA 
database.  Insurance type was used as a proxy for socio-economic status.   
 
Mental Health Conditions 
We identified which children in our cohort developed mental health conditions by the 
following International Classification of Diseases, ninth revision (ICD-9) diagnostic codes: 
disruptive behavior disorder (DBD, 312.*), attention-deficit hyperactivity disorder (ADHD, 
314.*), anxiety (300.*), depression (311.*), sleep disturbance (307.4), or adjustment disorder 
(309.*) recorded after 37 months of age.    
 
Psychotropic Drug Treatment 
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We identified psychotropic drug treatment by extracting prescriptions that were 
dispensed at hospitals and community pharmacies participating in INPC.  Psychotropic drug 
treatments of interest included stimulant medications, non-stimulants, alpha-2-agonists, atypical 
antipsychotics, sleep agents, and selective serotonin reuptake inhibitors.  For a complete list, see 
Table 1.  
 
Statistical Analysis  
Bivariate analyses of parental report of IPV, parental depressive symptoms, and socio-
demographic characteristics were performed using the chi2 test.  Since parental mood and IPV 
were significantly correlated (p ≤ 0.05), we sought to determine the relative contribution of each 
exposure to the outcomes of interest by creating a separate “early risk factor” variable with 4 
categories for (IPV only, parental depressive symptoms only, both IPV and parental depressive 
symptoms, and none).  Logistic regression models were used to assess the association between 
this new variable and each mental health diagnosis, adjusting for child gender, race/ethnicity, and 
insurance.  Additional models tested associations between the early risk factor variable and a 
child having been prescribed psychotropic medication.  Adjusted odds ratios (AORs) and 95% 
confidence intervals (CIs) were calculated for each model.  All analyses were performed using 
Stata 11 (StataCorp, College Station, TX, 2010).   
 
Results 
There were 2,422 subjects in the study cohort.  See Table 1 for sample characteristics.  
Approximately 52% of the sample was male and a large proportion was black (40.6%) or 
Hispanic/Latino (45.5%). The sample was 10.5% white, and a majority had public insurance 
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(90%).  By age 3, IPV and depressive symptoms together were reported by 2.4% (n=58) of 
parents, 3% (n=69) reported IPV only, 29% (n=704) reported depressive symptoms only and 
65.7% (n=1,591) reported neither.   
The rate of subsequent mental health disorder between age 3 to 6 varied by diagnosis: 
ADHD (3.3%); DBD (8.7%); anxiety (0.7%); depression (0.4%); sleep problems (0.3%) and 
adjustment disorder (1.7%) based on ICD-9 administrative billing data (See Table 2).  
Approximately 2% of children had been prescribed psychotropic medication based on pharmacy 
claims data.   
Based on the Fisher’s exact or Chi2 test, the prevalence of ADHD after age 3 was 
significantly associated with parent-reported depressive symptoms (4.5% vs. 2.8%, p≤0.03).  The 
prevalence of ADHD among children exposed to IPV in the first 3 years of life almost reached 
statistical significance (6.3% vs. 3.1%, p=0.06).  Children whose parents reported depressive 
symptoms had a higher likelihood of receiving psychotropic medication (2.9% vs. 1.6%, 
p≤0.03). 
Results of multivariable logistic regression revealed significant associations between the 
combination of parental IPV and depressive symptoms and preschool-onset ADHD (AOR 4.0; 
95% CI: 1.5-10.9), after adjusting for child gender, race/ethnicity, and insurance type.  
Additionally, parental depressive symptoms before age 3 was associated with a child having 
been prescribed psychotropic medication after age 3 (AOR: 1.9; 95% CI: 1.0-3.4).  Multivariable 
logistic regression models for other preschool mental health diagnoses were not statistically 
significant (See Table 3).  
For the subset of children exposed to parental depression and prescribed a psychotropic 
medication (n=20), 75% of medications were for ADHD.  The other medications prescribed were 
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selective serotonin reuptake inhibitors.  Other than for ADHD, a majority of preschoolers with 
mental health conditions were not routinely prescribed psychotropic medication (See Table 4).   
 
Comment 
 In this study of 2,422 children, 5.2% of parents reported IPV and 32% reported 
depressive symptoms at least once during routine pediatric visits within the first three years of a 
child’s life.  Roughly 2% of the sample reported both.  Children whose parents reported both IPV 
and parental depressive symptoms before age three were more likely to be diagnosed with 
ADHD after age 3 when compared to children who were not exposed to either IPV or parental 
depressive symptoms, and children with parents who reported depressive symptoms only were 
more likely to later be prescribed psychotropic medication compared to children without 
exposure to IPV or parental depressive symptoms, even after adjusting for gender, race/ethnicity 
and insurance type.   
Our study supports existing literature finding that IPV exposure is associated with 
significant childhood mental health and behavioral concerns.11,43-45  However, ours is the first 
prospective study within a pediatric clinical setting.  Moreover, our study is one of the first to 
examine associations among IPV exposure, parental depression, and associated behavioral health 
outcomes among preschoolers.  In our sample, exposure to both IPV and parental depression 
before 3 years of age was associated with preschool-onset ADHD.  This study contributes to a 
growing body of evidence that social risk factors can negatively impact children’s functioning, 
which can lead to alterations in their stress response systems and put them at greater risk for 
negative health outcomes as they age.15,21,46-48  It also supports the trend toward identifying 
ADHD in the preschool years and highlighting the pediatrician’s important role in this early 
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identification.49  In our study, preschoolers exposed to a parent who reported depressive 
symptoms within the first 3 years of life were more likely to have been prescribed psychotropic 
drug treatment, especially stimulants.  However, unless the preschooler had a diagnosis of 
ADHD, the majority of preschoolers with mental health conditions were not prescribed 
psychotropic medication.  
Pediatricians play a critical role in providing continuous care for families, performing 
surveillance of development and behavior, and addressing academic and health issues as children 
enter school.12,50 Children in families reporting IPV, past or present, should be screened for 
mental health conditions, and monitored over time for behavioral concerns and poor functioning.  
Our study support the findings that the presence of both IPV and parental depression increase the 
risk of poor functioning among elementary-school age children15 but demonstrates that 
significant effects can occur in children as young as 3 years of age.    
The prevalence of IPV in our sample was 5.2%, similar to other studies in pediatric 
settings.39,51-53  A variety of methods are effective for eliciting sensitive health risks such as 
IPV.54  In our study parents may have left the IPV screening questions blank for a number of 
reasons.  Mothers may fear for their own safety and the safety of their children should disclosure 
of IPV become known to the perpetrator.55  However, poor literacy or insufficient time may also 
have caused non-responses.  Nonetheless, active surveillance of IPV and parental depression by 
primary care pediatricians allows for early intervention efforts within the medical home, which 
may ultimately help prevent subsequent mental health issues.  
Another important feature that distinguishes this study from previous research in the field 
is the sample population from which the subjects were drawn.  Whereas previous studies drew 
primarily from battered women’s shelters or populations of dependent children whose mothers 
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were victims of police-reported or court-reported IPV, this study drew prospectively from the 
general population of children whose caregivers screened positive for IPV in one of four 
community pediatric practice sites.  Moreover, we collected data within one cohort, thereby 
reducing the risk of bias that is often present in case control designs.  Unlike cross-sectional 
studies, which only describe one point in time, our approach shows the temporal relationship 
between early IPV, parental depressive symptoms and later preschool mental health problems.   
Lastly, we elected to use administrative ICD-9 billing data to classify behavioral health 
outcomes of interest.  While this data source has some limitations, coding errors tend to be 
random and are unlikely to create a bias in our study.  It is known that depressed mothers, with 
or without concurrent IPV, often have more concerns regarding their children’s behavior.56,57  
Social desirability and recall bias are, therefore, more likely to bias studies relying on parental 
report of child behavior, especially if the reporting parent has a known history of IPV or 
depression.58   
As with all studies, there are limitations that should be considered when interpreting our 
results.  Because our study was observational, we may not have been able to account for all 
possible confounders, such as concurrent child abuse.  We did make every effort, however, to 
control for the most salient confounders by adjusting for socio-demographic characteristics, IPV 
and parental depressive symptoms.  Also, our characterization of IPV exposure was only loosely 
based on validated surveillance questions adapted from the Partner Violence Screen.59  The 
surveillance item, “feeling safe at home,” may have low specificity in detect intimate partner 
violence.60  However, asking whether a parent has been “kicked, hit or slapped” by a partner is 
correlated with IPV, and has been used alone or as part of a brief screener suitable for primary 
care.51,61  We elected to include both items on the CHICA PSF.  Based on previous work, we 
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know that when the two IPV surveillance items are printed on the PSF, parents will respond to 
those items 88.1% of the time.36  In addition, there is evidence that mothers may prefer the use of 
indirect or general screening questions when children are present.62,63  
The method of capturing parental depressive symptoms changed during the study from 
the PHQ-2 to EPDS-3.  While using the PHQ-2 to detect depression in primary care settings is 
valid,41 surveillance items in CHICA were changed to the EPDS-3 because the EPDS-3 was 
validated for postpartum depression.42  Moreover, scores from the EPDS or the PHQ-9, from 
which the PHQ-2 is derived, are often concordant when using either instrument to screen for 
major depression in the clinical care setting.64  
Pediatricians should increase their efforts to screen children under the age of 3 
preferentially for the possibility of IPV and other social risk factors whenever a parent or teacher 
raises behavioral concerns.51,65 Should early IPV and parental depression exposure be identified, 
pediatricians can perform active surveillance at each subsequent visit for emerging behavioral 
issues and maternal-child interaction problems related to impaired maternal functioning.  In 
addition, treatments aimed at ameliorating parental depression symptoms can lead to reductions 
in child behavior problems, and should be part of the treatment plan for children with behavioral 
or mental health disorders.66  Early identification of family psychosocial risk factors may 
ultimately translate into improved mental health outcomes for children.67   
 
Conclusion 
 Children whose parents report IPV and depressive symptoms before age three are at 
increased risk for the development of preschool-onset ADHD, and those whose parents report 
depressive symptoms only are more likely to be prescribed psychotropic medications in their 
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preschool years.  Pediatricians play a critical role in performing active, ongoing surveillance of 
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Stimulants	 methylphenidate, Ritalin, Methylin, Ritalin-SR, 
Methylin-ER, Metadate-EF, Ritalin LA, Metadate CD, 
dexmethylphenidate, Focalin, Adderall, Adderall XR, 
dextroamphetamine, Dexedrine, dextrostat, Dexedrine 
spansules, and Concerta	
Non‐stimulants	 Strattera/Atomoxetine, Bupropion/Wellbutrin, 
Wellbutrin SR, and Wellbutrin XL	
Alpha‐2‐agonists	 Tenex/Guanfacine, Intuniv, Clonidine/Catapres, and 
Kapvay	































































ICD‐9=	International	Statistical Classification of Diseases and Related Health Problems, Ninth 
Edition 





















AOR	 95%	CI	 AOR	 95%	CI	 AOR	 95%	CI	
ADHD	 1.8	 0.5‐6.1	 1.5	 0.9‐2.5	 4.0	 1.5‐10.9	
DBD	 1.1	 0.4‐2.5	 1.1	 0.8‐1.5	 1.4	 0.6‐3.5	
Anxiety	 ‐‐‐	 ‐‐‐	 0.5	 0.1‐18.0	 2.3	 0.3‐18.0	
Depression	 ‐‐‐	 ‐‐‐	 1.8	 0.5‐6.7	 ‐‐‐	 ‐‐‐	
Sleep	Problem	 ‐‐‐	 ‐‐‐	 2.8	 0.6‐12.7	 ‐‐‐	 ‐‐‐	
Adjustment	Disorder	 ‐‐‐	 ‐‐‐	 1.5	 0.8‐3.0	 2.6	 0.6‐11.2	





















ADHD	(n=80)	 40	 40	 50.0%	
DBD	(n=209)	 34	 175	 16.3%	
Anxiety	(n=17)	 3	 14	 17.6%	
Depression	(n=9)	 3	 6	 33.3%	




ICD‐9=	International	Statistical Classification of Diseases and Related Health Problems, Ninth 
Edition 
ADHD:	attention‐deficit	hyperactivity	disorder	
DBD:	disruptive	behavior	disorder 
	
	
